IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.54▼ 0.05% USD/CLP994.16▼ 0.13% USD/COP3,303▼ 0.37% USD/PEN3.40▼ 0.09% USD/ARS1,544▼ 0.02% USD/UYU40.59▲ 3.32% USD/PYG6,196▲ 3.06% USD/BOB11.59▲ 2.15% USD/DOP60.59▲ 0.26% USD/CRC442.74▲ 1.24% USD/GTQ7.64▲ 3.24% USD/HNL26.91▲ 3.28% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 2.75% USD/TTD6.75▲ 2.58% EUR/BRL6.25▲ 0.30% BRENT 95.25 ▼ 0.62% WTI 88.19 ▼ 0.42% IRON ORE 161.91 — — COPPER 6.08 ▼ 0.03% GOLD 3,896 ▲ 0.25% SILVER 48.83 ▼ 0.42% SOY 1,232 ▲ 0.37% CORN 445.50 ▲ 0.68% WHEAT 593.25 ▲ 1.54% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.53 ▼ 0.10% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 ▼ 0.37% USD/PEN 3.40 ▼ 0.09% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 ▲ 3.32% USD/PYG 6,196 ▲ 3.06% USD/BOB 11.59 ▲ 2.15% USD/DOP 60.59 ▲ 0.26% USD/CRC 442.74 ▲ 1.24% USD/GTQ 7.64 ▲ 3.24% USD/HNL 26.91 ▲ 3.28% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▲ 0.30% BRENT 95.25 ▼ 0.62% WTI 88.19 ▼ 0.42% IRON ORE 161.91 — — COPPER 6.08 ▼ 0.03% GOLD 3,896 ▲ 0.25% SILVER 48.83 ▼ 0.42% SOY 1,232 ▲ 0.37% CORN 445.50 ▲ 0.68% WHEAT 593.25 ▲ 1.54% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Earnings Market Reports

Fleury Group Sustains Profit Growth Amid Corporate Client Shifts in Q1 2025

Fleury Group, Brazil’s largest diagnostic medicine provider since 1926, posted a 6.7% net income rise to R$179.3 million ($29.9 million) in Q1 2025, per...

By RT Staff Reporters · · 2 min read
Fleury Group Sustains Profit Growth Amid Corporate Client Shifts in Q1 2025
Fleury Group Sustains Profit Growth Amid Corporate Client Shifts in Q1 2025.

Fleury Group, Brazil’s largest diagnostic medicine provider since 1926, posted a 6.7% net income rise to R$179.3 million ($29.9 million) in Q1 2025, per its earnings release.

Revenue climbed 6.5% to R$2.2 billion ($366.7 million), though net income slightly missed analyst forecasts of R$182.3 million ($30.4 million). The century-old firm, employing over 22,000 staff and 4,900 physicians, offset a 1.9% drop in corporate client revenue.

This was achieved through strong consumer demand and the expansion of specialty clinics. Consumer-focused diagnostics drove growth, with São Paulo and Rio de Janeiro branches surging 9.6% and 8.4%, respectively.

Free daily brief — no card needed
Get every Market Reports story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Fleury’s Novos Elos vertical, spanning orthopedics and ophthalmology, jumped 17.9% to R$222.5 million ($37.1 million), now comprising 10% of total income.

Corporate segment declines stemmed from a key client exit and reduced dengue testing volumes against 2024’s high baseline. EBITDA rose 5.9% to R$547.6 million ($91.3 million), maintaining a 27.2% margin through cost discipline despite increased marketing spend.

Fleury Group Sustains Profit Growth Amid Corporate Client Shifts in Q1 2025
Fleury Group Sustains Profit Growth Amid Corporate Client Shifts in Q1 2025.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Leverage held at 1x EBITDA, with net debt of R$1.67 billion ($278.3 million) against R$5.32 billion ($886.7 million) equity. Executives emphasized cash-funded acquisitions over debt, citing Brazil’s 19-year-high interest rates.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

Fleury Navigates Challenges with Strategic Expansion

The strategy follows Fleury’s 2023 absorption of Pardini Group, which boosted annual revenue 44.9% to R$6.96 billion ($1.16 billion) and expanded its national footprint.

Analysts note persistent corporate segment challenges but highlight resilience through diversified brands like Weinmann and Diagnoson a +, which contribute 91% of revenue.

Shares closed at R$13.18 ($2.20) on May 8, 2025, with a market cap of R$7.05 billion ($1.18 billion). The firm faces tariff-related cost pressures but aims to counter through supplier negotiations and regional operational adjustments.

Fleury’s 31-brand portfolio and 185 service centers position it to capitalize on Brazil’s healthcare demand while navigating economic headwinds. With digital transformation initiatives underway and cautious M&A plans, the group balances growth ambitions against fiscal prudence in a volatile credit climate.

Live Company IntelligenceFleury S.A. — the full investor dossierCompany overview and the latest Rio Times coverage.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.